These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 138326)
21. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061 [TBL] [Abstract][Full Text] [Related]
22. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome. Prelević GM; Würzburger MI; Balint-Perić L; Puzigaća Z Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704 [TBL] [Abstract][Full Text] [Related]
23. Changes in androgens during treatment with four low-dose contraceptives. Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882 [TBL] [Abstract][Full Text] [Related]
24. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism. Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138 [TBL] [Abstract][Full Text] [Related]
25. Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism. Baxendale PM; Jacobs HS; James VH Clin Endocrinol (Oxf); 1983 May; 18(5):447-57. PubMed ID: 6223726 [TBL] [Abstract][Full Text] [Related]
26. Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment. Amice V; Bercovici JP; Nahoul K; Hatahet MH; Amice J J Clin Endocrinol Metab; 1989 Jan; 68(1):58-62. PubMed ID: 2521223 [TBL] [Abstract][Full Text] [Related]
27. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272 [TBL] [Abstract][Full Text] [Related]
28. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome. Falsetti L; Dordoni D; Gastaldi C; Gastaldi A Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960 [TBL] [Abstract][Full Text] [Related]
29. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. Rittmaster RS; Thompson DL J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol]. Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318 [TBL] [Abstract][Full Text] [Related]
31. A role for a non-androgenic anovulant in the management of hirsutism. McKenna TJ; Cunningham SK Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211 [TBL] [Abstract][Full Text] [Related]
32. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism. Anderson JA Br J Dermatol; 1978 Nov; 99(5):545-52. PubMed ID: 708628 [TBL] [Abstract][Full Text] [Related]
33. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104 [TBL] [Abstract][Full Text] [Related]
34. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination. Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism. Batukan C; Muderris II Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223 [TBL] [Abstract][Full Text] [Related]
36. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264 [TBL] [Abstract][Full Text] [Related]
37. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism]. Pugeat M; Nicolas MH; Déchaud H; Elmidani M J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798 [TBL] [Abstract][Full Text] [Related]
38. Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women. Baxendale PM; Jacobs HS; James VH Clin Endocrinol (Oxf); 1982 Jun; 16(6):595-603. PubMed ID: 6213322 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic alternatives for the hirsute woman. Bassaw B; Maharaj R; Ali A; Roopnarinesingh S West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080 [TBL] [Abstract][Full Text] [Related]
40. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use. Castelo-Branco C; Martínez de Osaba MJ; Pons F; Fortuny A Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]